Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (8)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche![Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs [Editorial]](https://bdoc.ofdt.fr/img_cache/d1ffcba1a67f9fdc5d72961dfe2d198d.png)
Article : Périodique
Article : Périodique
One of the major obstacles to hepatitis C virus (HCV) care in people who inject drugs (PWID) is the lack of treatment settings that are suitably adapted for the needs of this vulnerable population. Nevertheless, HCV treatment has been delivered [...]Article : Périodique
J. GREBELY ; P. BRUGGMANN ; M. BACKMUND ; G. J. DORE |The majority of hepatitis C virus (HCV) occurs among people who inject drugs (PWID), and the burden of HCV-related liver disease is still increasing. HCV treatment is safe and effective among PWID, and international guidelines encourage HCV trea[...]Article : Périodique
G. ROBAEYS ; J. GREBELY ; S. MAUSS ; P. BRUGGMANN ; J. MOUSSALLI ; A. DE GOTTARDI ; T. SWAN ; A. ARAIN ; A. KAUTZ ; H. STÖVER ; H. WEDEMEYER ; M. SCHAEFER ; L. TAYLOR ; M. BACKMUND ; O. DALGARD ; M. PRINS ; G. J. DORE |In the developed world, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). The burden of HCV-related liver disease in this group is increasing, but treatment uptake among PWID remains [...]Article : Périodique
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users |Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]Nouveauté
Bulletin : Périodique
International Journal of Drug Policy, Vol.26, n°10 - October 2015 - Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
J. GREBELY, Éditeur scientifique ; P. BRUGGMANN, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; G. J. DORE, Éditeur scientifique | 2015Bulletin : Périodique
International Journal of Drug Policy, Vol.26, n°11 - November 2015 - Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs
J. GREBELY, Éditeur scientifique ; P. BRUGGMANN, Éditeur scientifique ; C. TRELOAR, Éditeur scientifique ; G. J. DORE, Éditeur scientifique | 2015Bulletin : Périodique
International Journal of Drug Policy, Vol.47 - September 2017 - Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
J. GREBELY ; J. BRUNEAU ; P. BRUGGMANN ; M. HARRIS ; M. HICKMAN ; T. RHODES ; C. TRELOAR, Éditeur scientifique | 2017
